Market Movers: Top Brokerage Reports & Stock Picks for November 24, 2025 – Foreign vs. Domestic Views

By [Your Blog Name/Author Name] | Published: November 24, 2025

It is Monday morning, November 24, 2025. The pre-market hum on Dalal Street feels different today. The air is thick with the specific kind of electricity that only a fresh trading week brings, but there is an added layer of complexity. The Gift Nifty is trading at a premium, signaling a gap-up opening, yet traders are looking beyond the ticking prices. They are glued to their screens, deciphering the flood of fresh research reports hitting the desks of fund managers.

For the retail investor, the sheer volume of noise can be deafening. You have the foreign giants—Morgan Stanley, CLSA, and JP Morgan—looking at India through a lens of global macro-strategy. On the other side, you have domestic powerhouses like Motilal Oswal and ICICI Direct, digging their heels into the granular, on-the-ground realities of rural recovery and festival demand.

If you are trying to make sense of the chatter, you aren’t alone. In this deep dive, we are cutting through the financial jargon to bring you a human-readable, SEO-friendly digest of the top brokerage calls moving the Indian stock market right now.

The Big Picture: The FII vs. DII Narrative

Before we get into specific stocks, we must understand the battlefield. As of November 2025, the Indian market is witnessing a tug-of-war. Foreign Institutional Investors (FIIs) have been the “moody teenagers” of the market—hard to predict and quick to react to US bond yields. However, reports published this morning suggest a shift from broad-market selling to highly selective “sniper buying.”

Conversely, Domestic Institutional Investors (DIIs) remain the bedrock. Their reports today emphasize “structural growth” and “consumption durability.” While FIIs are chasing momentum, DIIs are hunting for value.

Key Takeaway Table: At a Glance

1. The Auto Sector Showdown: CLSA vs. Morgan Stanley

The most interesting battleground in today’s reports is undoubtedly the Auto sector. With the festive season dust settling, analysts are calculating the real winners.

CLSA on Mahindra & Mahindra (M&M)

CLSA has come out swinging for Mahindra & Mahindra (M&M), slapping an ‘Outperform’ rating with a revised target price of ₹4,417.

• The Thesis: It is not just about tractors anymore. CLSA analysts are betting big on M&M’s “growth gems”—specifically their dominance in the SUV market and the aggressive push into global pickups.

• The Logic: They see the company clocking a revenue CAGR of 15-40% across various segments over the next two years. If you are holding M&M, CLSA is essentially telling you that the engine is just getting warmed up. They believe the market hasn’t fully priced in the success of their new EV platform, INGLO.

Morgan Stanley on Maruti Suzuki

Contrast this with Morgan Stanley’s view on Maruti Suzuki. They remain ‘Overweight’ with a massive target of ₹18,489.

• The Thesis: Operating leverage. Morgan Stanley believes the heavy discounts that plagued the last quarter have peaked. Now, it is time for profit margins to expand as raw material costs stabilize.

• The Catch: However, they aren’t as sunny on the entire sector. They maintained a cautious stance on Bajaj Auto, hinting that two-wheeler valuations have run up too fast, too soon.

2. The Tech Pivot: JP Morgan on TCS

For the last year, the IT sector has been the “sleeping giant” of the Indian market. However, JP Morgan has thrown a lifeline to Tata Consultancy Services (TCS) today, maintaining an ‘Overweight’ rating with a target of ₹4,050.

Why Now?

This isn’t a generic “buy the dip” call. It is driven by a specific, game-changing event: TCS’s reported partnership with global investment firm TPG to invest $1 billion in a new data center business, theoretically dubbed ‘HyperVault’.

• The Strategic Shift: JP Morgan sees this as a masterstroke. It allows TCS to build capacity without wrecking its own balance sheet.

• Investor Signal: For investors, this signals that the big tech giants are finally moving from “cost-cutting” mode to “capex” mode. If the US economy achieves the elusive “soft landing” in 2026, TCS is positioned to capture the bulk of the AI-migration contracts.

3. The Infrastructure Bull: Citigroup on L&T

While everyone is watching India’s domestic election cycles, Citigroup is looking at the map. They continue to bang the drum for Larsen & Toubro (L&T) with a Buy rating and a ₹4,500 target.

Geographic Diversification is Key

Citi’s report highlights a crucial divergence. While domestic private capex is steady, L&T is winning big in the Middle East (Saudi Arabia’s Neom project) and seeing green shoots in Europe.

• The Number: Currently, international orders make up a significant chunk of their backlog.

• The Verdict: If domestic private capex picks up (which is currently 30% of their backlog), L&T is sitting on a powder keg of growth. Citi warns against betting against the “proxy for India’s growth.”

4. The Domestic Defenders: Motilal Oswal & ICICI Direct

While foreign brokers look at balance sheets and global liquidity, domestic brokerages often look at “thali economics”—what is the common man consuming and needing?

Healthcare: The Defensive Play

Motilal Oswal has identified Max Healthcare as a top pick for the week, forecasting a 15% upside.

• The Insight: This isn’t a short-term trade; it is a structural bet. They highlight that Max is doubling its bed capacity over the next 4-5 years.

• Why It Matters: In a country starving for quality healthcare infrastructure, this expansion pipeline provides “multi-year visibility.” For the defensive investor worried about market volatility, this is as close to a “sleep well at night” stock as you can get.

The Reliance Revival

It has been a quiet year for Reliance Industries (RIL), but domestic brokers are sensing a turnaround. Motilal Oswal points to the 19% YoY growth in Retail revenue, driven by the recent Diwali festive demand.

• The Narrative: The story is shifting from “Oil to Chemicals” (O2C) back to the consumer. With Jio adding 8.3 million subscribers and 5G engagement rising, the domestic view is that RIL is coiled for a breakout, estimating an EBITDA growth of 10-11% CAGR.

Niche Engineering: ICICI Direct

Sometimes the best money is made where the crowd isn’t looking. ICICI Direct is bullish on Sansera Engineering.

• The Angle: As global supply chains shift away from China (China+1 strategy), precision engineering firms in India are seeing order books swell. Sansera is shifting from purely auto-components to aerospace and defense, which commands higher margins.

5. The “Danger Zone”: Stocks with Caution Flags

Honest reporting means telling you what not to buy, or at least, what to watch carefully. A unique aspect of the reports published on November 24, 2025, is the caution around specific heavyweights.

HAL (Hindustan Aeronautics Ltd)

The stock is under intense scrutiny today. Following the recent (hypothetical) safety concerns regarding the Tejas fleet mentioned in defense reports, Choice Research notes that short-term turbulence is likely.

• The View: While the long-term order book is full, sentiment drives short-term price. It is a classic “good business, bad news cycle.” Investors are advised to wait for a dip before entering.

Petronet LNG

Jefferies remains bearish with an ‘Underperform’ rating.

• The Issue: Structural problems. Weak demand and global pricing pressures are squeezing margins. It is a stark reminder that being a monopoly doesn’t guarantee profits if the underlying commodity cycle turns against you.

6. Technical Outlook: Nifty 50 Levels to Watch

Beyond the fundamentals, what are the charts saying?

SBI Securities offers a poetic but cautionary take on the Nifty. They note that while the index is near record highs, the rally is “selective.” It is like a party where only the VIPs (Large Caps) are dancing, while the rest of the room (Mid and Small Caps) is sitting out.

• Support Level: 25,850. If Nifty holds this, the trend remains bullish.

• Resistance Level: 26,500. This is the ceiling to break for the next leg of the rally.

• The Warning: They warn that unless the broader market (Midcaps) participates, this rally could be fragile. A break below 25,850 could trigger profit booking down to 25,500.

Conclusion: Quality Over Momentum

If you distill over 100 pages of research reports published this morning into a single strategy, it would be this: Quality over Momentum.

The days of “buy anything and it goes up” seem to be paused for now. The foreign brokerages are chasing earnings visibility (M&M, L&T), while domestic brokerages are chasing consumption durability (Max Health, Reliance).

The Final Verdict for Your Portfolio:

• Aggressive Investors: Look at M&M and TCS. The risk is higher, but the growth triggers are imminent.

• Conservative Investors: Max Healthcare and HDFC Life offer safety nets in a market that feels slightly overextended.

As the trading bell rings and the ticker starts moving, remember that these reports are just maps, not the terrain. The market has a mind of its own, often defying the smartest analysts in the room. But today, at least, you know what the “smart money” is whispering.

Frequently Asked Questions (FAQ)

Q1: Which is the best stock to buy today, November 24, 2025?

Based on brokerage reports, M&M (CLSA) and Max Healthcare (Motilal Oswal) are top contenders for growth and stability, respectively.

Q2: What is the target price for TCS in November 2025?

JP Morgan has maintained an ‘Overweight’ rating on TCS with a target price of ₹4,050.

Q3: Why are foreign investors (FIIs) selling Indian stocks?

While FIIs have been net sellers recently due to global bond yields, reports today indicate they are selectively buying into Auto and Banking sectors.

Q4: Is the Indian stock market overvalued right now?

Some analysts, like those at Morgan Stanley, suggest that while Large Caps are fairly valued, certain segments of the Midcap and Two-Wheeler market (like Bajaj Auto) may be overextended.